Transce3nd, LLC Organon & Co. Transaction History
Transce3nd, LLC
- $295 Billion
- Q4 2024
A detailed history of Transce3nd, LLC transactions in Organon & Co. stock. As of the latest transaction made, Transce3nd, LLC holds 15 shares of OGN stock, worth $229. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15Holding current value
$229% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding OGN
# of Institutions
809Shares Held
207MCall Options Held
1.19MPut Options Held
910K-
Black Rock Inc. New York, NY32.6MShares$498 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA30.4MShares$465 Million0.01% of portfolio
-
Pacer Advisors, Inc. Malvern, PA11.2MShares$170 Million0.41% of portfolio
-
Massachusetts Financial Services CO Boston, MA9.9MShares$151 Million0.05% of portfolio
-
State Street Corp Boston, MA9.34MShares$143 Million0.01% of portfolio
About Organon & Co.
- Ticker OGN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 254,330,000
- Market Cap $3.89B
- Description
- Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...